These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9863502)
1. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS. Payen MC; De Wit S; Sommereijns B; Clumeck N Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502 [TBL] [Abstract][Full Text] [Related]
2. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598 [TBL] [Abstract][Full Text] [Related]
3. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488 [TBL] [Abstract][Full Text] [Related]
4. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. Bucher HC; Griffith L; Guyatt GH; Opravil M J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108 [TBL] [Abstract][Full Text] [Related]
7. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. Podzamczer D; Santín M; Jimenez J; Casanova A; Bolao F; Gudiol GR AIDS; 1993 Apr; 7(4):501-6. PubMed ID: 8507417 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919 [TBL] [Abstract][Full Text] [Related]
9. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC; Rimland D Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975 [TBL] [Abstract][Full Text] [Related]
10. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747 [TBL] [Abstract][Full Text] [Related]
11. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis]. Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144 [TBL] [Abstract][Full Text] [Related]
13. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472 [TBL] [Abstract][Full Text] [Related]
17. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236 [No Abstract] [Full Text] [Related]
18. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886 [TBL] [Abstract][Full Text] [Related]
19. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection. Dorrell L; McCallum AK; Snow MH; Ong EL AIDS Patient Care; 1995 Oct; 9(5):224-8. PubMed ID: 11361401 [No Abstract] [Full Text] [Related]
20. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]